en

PRODUCT DETAIL

Repaglinide Teva 2 mg tablety

Code 78286
MA number EU/1/09/530/015
Product Form: tbl 360x2 mg (blister Al/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BX Other blood glucose lowering drugs, excl. insulins
A10BX02 Repaglinide
Shelf life: 24
Container: blister Al/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 29.06.2009
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 30.03.2022
eu-flag.png sk-flag.png